| |
Total |
THR |
TKR |
RTHR |
| Number (n) |
106 |
57 |
30 |
19 |
| Gender (proportion of female %) |
58 |
58 |
57 |
56 |
| Age (years) |
68 ± 12 |
67 ± 13 |
71 ± 9 |
70 ± 13 |
| Comorbidities |
|
|
|
|
| Body mass index (kg/m2) |
27 ± 4 |
24 ± 4 |
28 ± 5 |
26 ± 4 |
| Median ASA score (Q1;Q3) |
2 (2;3) |
2 (2;3) |
2 (2;3) |
2 (2;3) |
| Cardio-vascular disease history (%) |
29 |
28 |
37 |
22 |
| Antiplatelet agents at D-30 (%) |
25 |
25 |
33 |
17 |
| Anticoagulant agents at D-30 (%) |
8 |
9 |
7 |
11 |
| Hemoglobin level at D-1 (g/dL) |
13.7 ± 1.2 |
13.9 ± 1.1 |
13.3 ± 1.0 |
13.6 ± 1.6 |
| Perioperative period |
|
|
|
|
| Tranexamic acid (%) |
76 |
74 |
73 |
89 |
| Intraoperative dose (mg/kg) |
16 ± 15 |
15 ± 10 |
14 ± 9 |
47 ± 18 |
| Dose per 24h (mg/kg/24h) |
75 ± 25 |
71 ± 19 |
69 ± 20 |
102 ± 36 |
| Fluids (intraoperative and RR, in mL) |
2094 ± 747 |
2079 ± 646 |
1683 ± 549 |
2861 ± 782 |
| Postoperative intravenous iron (%) |
86 |
86 |
83 |
94 |
| Transfusion |
|
|
|
|
| Autologous transfusion (%) |
0 |
0 |
0 |
0 |
| Transfusion (between D0 et D+5, in %) |
18 |
14 |
10 |
44 |
| Number of transfused patients (n) |
19 |
8 |
3 |
8 |
| Median number of RBC units (Q1,Q3) |
2 (2;2.5) |
2 (1;2) |
3 (2,5;4) |
2 (2;2,75) |
| Mean Hb transfusional threshold (g/dL) |
8.7 ± 1.1 |
8.8 ± 1.4 |
8.2 ± 1.0 |
8.8 ± 1.0 |
THR: Total Hip Replacement; TKR: Total Knee Replacement; RTHR: Revision
Total Hip Replacement; ASA: American Society of Anesthesiology; RR: Recovery
Room; RBC: Red Blood Cell; Hb: Hemoglobin